CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous disease

被引：10

作者：

Quinn, John ^{[1
]}

Percy, Laura ^{[1
]}

Glassford, Janet ^{[1
]}

Somana, Kathy ^{[2
]}

Rodriguez-Justo, Manuel ^{[3
]}

Yong, Kwee ^{[1
]}

机构：

[1] UCL, Inst Canc, Dept Haematol, London, England

[2] UCL, Dept Cytogenet, London, England

[3] UCL, Dept Histopathol, London, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷 / 01期

关键词：

CD20; Cyclin D; Myeloma; DYSREGULATION;

D O I：

10.1111/j.1365-2141.2009.08030.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：156 / 159

页数：4

共 10 条

[1] Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma [J].

Bergsagel, PL ;

Kuehl, WM ;

Zhan, FH ;

Sawyer, J ;

Barlogie, B ;

Shaughnessy, J .

BLOOD, 2005, 106 (01) :296-303

[2] Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma [J].

Ely, S ;

Di Liberto, M ;

Niesvizky, R ;

Baughn, LB ;

Cho, HJ ;

Hatada, EN ;

Knowles, DM ;

Lane, J ;

Chen-Kiang, S .

CANCER RESEARCH, 2005, 65 (24) :11345-11353

[3] Anti-CD20 monoclonal antibody therapy in multiple myeloma [J].

Kapoor, Prashant ;

Greipp, Patricia T. ;

Morice, William G. ;

Rajkumar, S. Vincent ;

Witzig, Thomas E. ;

Greipp, Philip R. .

BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) :135-148

[4] Genetic abnormalities and patterns of antigenic expression in multiple myeloma [J].

Mateo, G ;

Castellanos, M ;

Rasillo, A ;

Gutiérrez, NC ;

Montalbán, MA ;

Martín, ML ;

Hernández, JM ;

López-Berges, MC ;

Montejano, L ;

Bladé, J ;

Mateos, MV ;

Sureda, A ;

de la Rubia, J ;

Díaz-Mediavilla, J ;

Pandiella, A ;

Lahuerta, JJ ;

Orfao, A ;

San Miguel, JF .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3661-3667

[5] Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance [J].

Matsui, William ;

Wang, Qiuju ;

Barber, James P. ;

Brennan, Sarah ;

Smith, B. Douglas ;

Borrello, Ivan ;

McNiece, Ian ;

Lin, Lan ;

Ambinder, Richard F. ;

Peacock, Craig ;

Watkins, D. Neil ;

Huff, Carol Ann ;

Jones, Richard J. .

CANCER RESEARCH, 2008, 68 (01) :190-197

[6] Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy [J].

Moreau, P ;

Facon, T ;

Leleu, X ;

Morineau, N ;

Huyghe, P ;

Harousseau, JL ;

Bataille, R ;

Avet-Loiseau, H .

BLOOD, 2002, 100 (05) :1579-1583

[7] CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma [J].

Robillard, N ;

Avet-Loiseau, H ;

Garand, R ;

Moreau, P ;

Pineau, D ;

Rapp, MJ ;

Harousseau, JL ;

Bataille, R .

BLOOD, 2003, 102 (03) :1070-1071

[8] Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma [J].

Sahara, N ;

Takeshita, A ;

Shigeno, K ;

Fujisawa, S ;

Takeshita, K ;

Naito, K ;

Ihara, M ;

Ono, T ;

Tamashima, S ;

Nara, K ;

Ohnishi, K ;

Ohno, R .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) :882-885

[9]

SANMIGUEL JF, 1991, BRIT J HAEMATOL, P77

[10] The molecular classification of multiple myeloma [J].

Zhan, Fenghuang ;

Huang, Yongsheng ;

Colla, Simona ;

Stewart, James P. ;

Hanamura, Ichiro ;

Gupta, Sushil ;

Epstein, Joshua ;

Yaccoby, Shmuel ;

Sawyer, Jeffrey ;

Burington, Bart ;

Anaissie, Elias ;

Hollmig, Klaus ;

Pineda-Roman, Mauricio ;

Tricot, Guido ;

van Rhee, Frits ;

Walker, Ronald ;

Zangari, Maurizio ;

Crowley, John ;

Barlogie, Bart ;

Shaughnessy, John D., Jr. .

BLOOD, 2006, 108 (06) :2020-2028

← 1 →